Thomas Dohlman, MD
Ophthalmologist, Department of Ophthalmology
Assistant Professor of Ophthalmology, Harvard Medical School
Image
Thomas Dohlman, MD
Ophthalmologist, Department of Ophthalmology
Assistant Professor of Ophthalmology, Harvard Medical School
Medical Services
Languages
English
Education
Undergraduate School
Massachusetts Institute of Technology
2007
Cambridge
MA
Medical School
University if Massachusetts Medical School
2011
Worcester
MA
Residency
NY Presbyterian Hospital/Weill Cornell Medical School
2018
New York
NY
Fellowship
Schepens Eye Research Institute/Mass Eye and Ear Boston
2014
Boston
MA
Certifications
American Board of Ophthalmology (General)
Professional History
Dr. Dohlman is a clinician-scientist who specializes in the medical and surgical management of corneal and external eye diseases. Dr. Dohlman earned his BS degree from MIT and MD from the University of Massachusetts Medical School. He then completed a Postdoctoral Research Fellowship in Corneal Immunology and Corneal Transplantation Immunology at the Schepens Eye Research Institute of Mass. Eye and Ear. He went on to complete his residency training in ophthalmology at New York Presbyterian/Weill Cornell Medical College, after which he returned to Mass. Eye and Ear for further subspecialty training as an Advanced Two-Year Combined Clinical and Research Fellow in Cornea, Refractive Surgery, and External Disease. Dr. Dohlman cares for pediatric and adult patients with corneal disease and conducts basic science and clinical research in the areas of corneal immunology and inflammation, corneal transplantation immunology, corneal fibrosis/scarring and ocular surface disease.
Publications
Clinical Characteristics of Ocular Graft-Versus-Host Disease Associated With Tapering of Immunosuppressive Drugs. View Abstract
Incidence and Microbiology of Endophthalmitis in Eyes With a Type 1 Boston Keratoprosthesis: A Systematic Review and Meta-Analysis. View Abstract
Myeloid-Derived Suppressor Cells Enhance Wound Healing in a Murine Model of Corneal Injury. View Abstract
Corneal Myofibroblasts Suppress T-Cell Immunity in Corneal Transplantation. View Abstract
Keratoprosthesis Indications, Outcomes, and Future Directions. View Abstract
Role of PD-L1 in Regulatory T Cell-Mediated Suppression of Corneal Neovascularization. View Abstract
IL-6 amplifies corneal transplant alloimmunity by inducing dysfunctional IFN-?- secreting Treg through the VEGFA-VEGFR1 axis. View Abstract
Surgical Outcomes in Patients Diagnosed With Corneal Opacity: An IRIS (Intelligent Research in Sight) Registry Study. View Abstract
Innovation in Keratoprostheses: A Review of Modern Devices and Strategies for Preventing and Managing Complications. View Abstract
Subconjunctival Adalimumab for Noninfectious Uveitis: A Prospective Pilot Study. View Abstract
Neurotrophic Keratopathy in Pediatric Population: An IRIS® Registry Report. View Abstract
Visual Outcomes of Limbal Stem Cell Transplantation in the IRIS® Registry. View Abstract
Optical Coherence Tomography Angiography in Patients With the Boston Keratoprosthesis Type 1. View Abstract
Immunology in corneal transplantation-From homeostasis to graft rejection. View Abstract
State-of-the-Art Review: Ocular Infections. View Abstract
Executive Summary: State-of-the-Art Review: Ocular Infections. View Abstract
Assessment of Corneal Graft Outcomes in a Murine Model of Endothelial Keratoplasty. View Abstract
Neuropeptide alpha-Melanocyte stimulating hormone preserves corneal endothelial morphology in a murine model of Fuchs dystrophy. View Abstract
Complications After Pediatric Penetrating Keratoplasty: An IRIS Registry Study. View Abstract
Potential applications of mesenchymal stem cells in ocular surface immune-mediated disorders. View Abstract
Corneal Opacity in the United States: An American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) Study. View Abstract
Immunopathological mechanisms and clinical manifestations of ocular graft-versus-host disease following hematopoietic stem cell transplantation. View Abstract
Ocular Blast Injuries in Military and Civilian Mass-casualty Settings. View Abstract
Myeloid-derived suppressor cells promote allograft survival by suppressing regulatory T cell dysfunction in high-risk corneal transplantation. View Abstract
Visual outcomes of children undergoing penetrating keratoplasty in the US. View Abstract
Suppression of Neovascularization by Topical and Subconjunctival Bevacizumab After High-Risk Corneal Transplantation. View Abstract
Therapeutic Effects of Stimulating the Melanocortin Pathway in Regulating Ocular Inflammation and Cell Death. View Abstract
Effector T Cells Promote Fibrosis in Corneal Transplantation Failure. View Abstract
Concurrence of Ocular Cicatricial Pemphigoid in Chronic Ocular Graft-Versus-Host Disease. View Abstract
The Neuropeptide a-Melanocyte-Stimulating Hormone Prevents Persistent Corneal Edema following Injury. View Abstract
The prophylactic value of TNF-a inhibitors against retinal cell apoptosis and optic nerve axon loss after corneal surgery or trauma. View Abstract
Insights into mustard gas keratopathy- characterizing corneal layer-specific changes in mice exposed to nitrogen mustard. View Abstract
Temporal keratoconus in a pediatric patient. View Abstract
The impact of donor diabetes on corneal transplant immunity. View Abstract
Insights into mustard gas keratopathy: Characterizing corneal layer-specific changes in mice exposed to nitrogen mustard. View Abstract
Eye Swelling and Decreased Vision in a Patient With Autism. View Abstract
Conventional type I migratory CD103+ dendritic cells are required for corneal allograft survival. View Abstract
Descemet Stripping Only Technique for Corneal Endothelial Damage in Mice. View Abstract
Penetrating Keratoplasty: Indications and Graft Survival by Geographic Region. View Abstract
Ocular pain in ocular graft-versus-host disease patients with neurotrophic keratopathy. View Abstract
Prevalence of neurotrophic keratopathy in patients with chronic ocular graft-versus-host disease. View Abstract
Modulating the tachykinin: Role of substance P and neurokinin receptor expression in ocular surface disorders. View Abstract
A Novel Murine Model of Endothelial Keratoplasty. View Abstract
Bevacizumab in High-Risk Corneal Transplantation: A Pilot Multicenter Prospective Randomized Control Trial. View Abstract
Immune regulation of the ocular surface. View Abstract
Novel adaptation of a running suture technique in a mouse model of corneal transplantation. View Abstract
Limbal Stem Cell Deficiency Associated With Herpes Keratitis. View Abstract
A Review of Ocular Graft-versus-Host Disease: Pathophysiology, Clinical Presentation and Management. View Abstract
Prevalence and Risk Factors Associated With Corneal Perforation in Chronic Ocular Graft-Versus-Host-Disease. View Abstract
Ocular redness - I: Etiology, pathogenesis, and assessment of conjunctival hyperemia. View Abstract
Ocular redness - II: Progress in development of therapeutics for the management of conjunctival hyperemia. View Abstract
Advances in the Medical Management of Neurotrophic Keratitis. View Abstract
Challenges in Acanthamoeba Keratitis: A Review. View Abstract
Efficacy of cyanoacrylate tissue adhesive in the management of corneal thinning and perforation due to microbial keratitis. View Abstract
Efficacy and retention of silicone punctal plugs for treatment of dry eye in patients with and without ocular graft-versus-host-disease. View Abstract
Prevalence of Persistent Corneal Epithelial Defects in Chronic Ocular Graft-Versus-Host Disease. View Abstract
Restoration of Regulatory T-Cell Function in Dry Eye Disease by Antagonizing Substance P/Neurokinin-1 Receptor. View Abstract
The role of Th17 immunity in chronic ocular surface disorders. View Abstract
Placoid choroidopathy after bilateral uncomplicated descemet's membrane endothelial keratoplasty. View Abstract
Evaluation of signs and symptoms of ocular surface disease after intravitreal injection. View Abstract
Methods for Assessing Corneal Opacity. View Abstract
Thrombospondin-1 in ocular surface health and disease. View Abstract
Reduced Efficacy of Low-dose Topical Steroids in Dry Eye Disease Associated With Graft-versus-Host Disease. View Abstract
Interleukin-6 neutralization prolongs corneal allograft survival. View Abstract
Proangiogenic Function of T Cells in Corneal Transplantation. View Abstract
In Reply. View Abstract
T Cell-Derived Granulocyte-Macrophage Colony-Stimulating Factor Contributes to Dry Eye Disease Pathogenesis by Promoting CD11b+ Myeloid Cell Maturation and Migration. View Abstract
Ocular Decompression Retinopathy After Uncomplicated Cataract Surgery in a Patient With a History of Narrow-Angle Glaucoma. View Abstract
Immediately sequential bilateral cataract surgery: advantages and disadvantages. View Abstract
Tear film assessments for the diagnosis of dry eye. View Abstract
Ocular Decompression Retinopathy After Uncomplicated Cataract Surgery in a Patient With a History of Narrow-Angle Glaucoma. View Abstract
A Clinical Trial Comparing the Safety and Efficacy of Topical Tacrolimus versus Methylprednisolone in Ocular Graft-versus-Host Disease. View Abstract
E-Selectin Mediates Immune Cell Trafficking in Corneal Transplantation. View Abstract
Effect of Penetrating Keratoplasty and Keratoprosthesis Implantation on the Posterior Segment of the Eye. View Abstract
In Vivo Expansion of Regulatory T Cells by Low-Dose Interleukin-2 Treatment Increases Allograft Survival in Corneal Transplantation. View Abstract
Graft Site Microenvironment Determines Dendritic Cell Trafficking Through the CCR7-CCL19/21 Axis. View Abstract
Dry Eye Disease After Refractive Surgery. View Abstract
VEGF-trap aflibercept significantly improves long-term graft survival in high-risk corneal transplantation. View Abstract
Reduced Corneal Endothelial Cell Density in Patients With Dry Eye Disease. View Abstract
Effects of corneal nerve density on the response to treatment in dry eye disease. View Abstract
Corneal inflammation after miniature keratoprosthesis implantation. View Abstract
Extraorbital lacrimal gland excision: a reproducible model of severe aqueous tear-deficient dry eye disease. View Abstract
Mesenchymal stem cells home to inflamed ocular surface and suppress allosensitization in corneal transplantation. View Abstract
CCR7 is critical for the induction and maintenance of Th17 immunity in dry eye disease. View Abstract
Soluble vascular endothelial growth factor receptor-3 suppresses allosensitization and promotes corneal allograft survival. View Abstract
A novel murine model for keratoprosthesis. View Abstract
Corneal Lymphatics: Role in Ocular Inflammation as Inducer and Responder of Adaptive Immunity. View Abstract
CCL-21 conditioned regulatory T cells induce allotolerance through enhanced homing to lymphoid tissue. View Abstract
The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease. View Abstract
PDE4 inhibition suppresses IL-17-associated immunity in dry eye disease. View Abstract
Locations